JSKN003 Versus Physician Choiced Treatment in Patients With HER2-positive and Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-Fu, and Irinotecan
Clinical trial NCT07384377 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07384377
- Sponsor
- Shanghai JMT-Bio Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-06
- Primary completion
- 2027-11-30
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.